177 related articles for article (PubMed ID: 31540114)
21. Long-term Outcomes of Carbon-ion Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Uterine Cervix.
Okonogi N; Wakatsuki M; Kato S; Shiba S; Kobayashi D; Kiyohara H; Karasawa K; Ohno T; Nakano T; Kamada T; Shozu M;
Anticancer Res; 2018 Jan; 38(1):457-463. PubMed ID: 29277809
[TBL] [Abstract][Full Text] [Related]
22. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.
Wang R; Wang L; Li Y; Hu H; Shen L; Shen X; Pan Y; Ye T; Zhang Y; Luo X; Zhang Y; Pan B; Li B; Li H; Zhang J; Pao W; Ji H; Sun Y; Chen H
Clin Cancer Res; 2014 Aug; 20(15):4107-14. PubMed ID: 24850843
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of carbon ion radiation therapy for locally recurrent rectal cancer.
Mobaraki A; Ohno T; Yamada S; Sakurai H; Nakano T
Cancer Sci; 2010 Aug; 101(8):1834-9. PubMed ID: 20500516
[TBL] [Abstract][Full Text] [Related]
24. Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.
Yanagawa T; Saito K; Kiyohara H; Ohno T; Nakano T; Takagishi K
Radiat Oncol; 2015 Dec; 10():259. PubMed ID: 26691334
[TBL] [Abstract][Full Text] [Related]
25. Cost-Effectiveness of Carbon Ion Radiation Therapy for Skull Base Chordoma Utilizing Long-Term (10-Year) Outcome Data.
Sprave T; Verma V; Sterzing F; Bruckner T; Hees K; Land B; Jäkel O; Herfarth K; Debus J; Uhl M
Anticancer Res; 2018 Aug; 38(8):4853-4858. PubMed ID: 30061259
[TBL] [Abstract][Full Text] [Related]
26. Carbon-ion radiotherapy for isolated para-aortic lymph node recurrence from colorectal cancer.
Isozaki Y; Yamada S; Kawashiro S; Yasuda S; Okada N; Ebner D; Tsuji H; Kamada T; Matsubara H
J Surg Oncol; 2017 Dec; 116(7):932-938. PubMed ID: 28727901
[TBL] [Abstract][Full Text] [Related]
27. Multi-Institutional Retrospective Analysis of Carbon-Ion Radiotherapy for Patients with Locally Advanced Adenocarcinoma of the Uterine Cervix.
Okonogi N; Ando K; Murata K; Wakatsuki M; Noda SE; Irie D; Tsuji H; Shozu M; Ohno T
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072676
[TBL] [Abstract][Full Text] [Related]
28. Carbon-ion radiotherapy for patients with advanced stage non-small-cell lung cancer at multicenters.
Karube M; Yamamoto N; Shioyama Y; Saito J; Matsunobu A; Okimoto T; Ohno T; Tsuji H; Nakano T; Kamada T
J Radiat Res; 2017 Sep; 58(5):761-764. PubMed ID: 28992088
[TBL] [Abstract][Full Text] [Related]
29. Clinical Indications for Carbon Ion Radiotherapy.
Mohamad O; Yamada S; Durante M
Clin Oncol (R Coll Radiol); 2018 May; 30(5):317-329. PubMed ID: 29402598
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors of acute skin reactions to carbon ion radiotherapy for the treatment of malignant bone and soft tissue tumors.
Takakusagi Y; Saitoh JI; Kiyohara H; Oike T; Noda SE; Ohno T; Nakano T
Radiat Oncol; 2017 Nov; 12(1):185. PubMed ID: 29166945
[TBL] [Abstract][Full Text] [Related]
31. Carbon-ion re-irradiation for recurrences after initial treatment of stage I non-small cell lung cancer with carbon-ion radiotherapy.
Karube M; Yamamoto N; Tsuji H; Kanematsu N; Nakajima M; Yamashita H; Nakagawa K; Kamada T
Radiother Oncol; 2017 Oct; 125(1):31-35. PubMed ID: 28784437
[TBL] [Abstract][Full Text] [Related]
32. Carbon ion radiotherapy combined with immunotherapy: synergistic anti-tumor efficacy and preliminary investigation of ferroptosis.
Huang Q; Hu J; Chen L; Lin W; Yang J; Hu W; Gao J; Zhang H; Lu JJ; Kong L
Cancer Immunol Immunother; 2023 Dec; 72(12):4077-4088. PubMed ID: 37777634
[TBL] [Abstract][Full Text] [Related]
33. Health Technology Assessment of Carbon-ion Beam Radiotherapy: A Systematic Review of Clinical Effectiveness and Safety for 54 Oncological Indications in 12 Tumour Regions.
Goetz G; Mitic M; Mittermayr T; Wild C
Anticancer Res; 2019 Apr; 39(4):1635-1650. PubMed ID: 30952702
[TBL] [Abstract][Full Text] [Related]
34. Intravenous dendritic cell administration enhances suppression of lung metastasis induced by carbon-ion irradiation.
Ando K; Fujita H; Hosoi A; Ma L; Wakatsuki M; Seino KI; Kakimi K; Imai T; Shimokawa T; Nakano T
J Radiat Res; 2017 Jul; 58(4):446-455. PubMed ID: 28339788
[TBL] [Abstract][Full Text] [Related]
35. Nano-Vesicles are a Potential Tool to Monitor Therapeutic Efficacy of Carbon Ion Radiotherapy in Prostate Cancer.
Yu Q; Li P; Weng M; Wu S; Zhang Y; Chen X; Zhang Q; Shen G; Ding X; Fu S
J Biomed Nanotechnol; 2018 Jan; 14(1):168-178. PubMed ID: 29463374
[TBL] [Abstract][Full Text] [Related]
36. Clinical trials involving carbon-ion radiation therapy and the path forward.
Lazar AA; Schulte R; Faddegon B; Blakely EA; Roach M
Cancer; 2018 Dec; 124(23):4467-4476. PubMed ID: 30307603
[TBL] [Abstract][Full Text] [Related]
37. Feasibility of carbon ion radiotherapy for locally advanced sinonasal adenocarcinoma.
Koto M; Hasegawa A; Takagi R; Sasahara G; Ikawa H; Mizoe JE; Jingu K; Tsujii H; Kamada T; Okamoto Y;
Radiother Oncol; 2014 Oct; 113(1):60-5. PubMed ID: 25287484
[TBL] [Abstract][Full Text] [Related]
38. Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapy.
Kasuya G; Ishikawa H; Tsuji H; Nomiya T; Makishima H; Kamada T; Akakura K; Suzuki H; Shimazaki J; Haruyama Y; Kobashi G; Tsujii H;
Cancer; 2016 Oct; 122(20):3225-3231. PubMed ID: 27351298
[TBL] [Abstract][Full Text] [Related]
39. Feasibility and Safety of Repeated Carbon Ion Radiotherapy for Locally Advanced Unresectable Pancreatic Cancer.
Okamoto M; Shiba S; Okazaki S; Miyasaka Y; Shibuya K; Kiyohara H; Ohno T
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562274
[TBL] [Abstract][Full Text] [Related]
40. Radiobiological issues in prospective carbon ion therapy trials.
Fossati P; Matsufuji N; Kamada T; Karger CP
Med Phys; 2018 Nov; 45(11):e1096-e1110. PubMed ID: 30421806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
